Today’s top gainers include the company CR Bard Inc. (NYSE:BCR) which is in the industry Medical Instruments & Supplies, gaining -0.26% today. In the last week its performance is -0.96%, and 11.24% for the past quarter. Currently, CR Bard Inc., BCR has a target price of 232.62, so today’s gain of -0.26% is a significant step towards its target price. The GAP today is therefore 0.00%.
CR Bard Inc. (NYSE:BCR), has a market cap of 16969.4, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 91.10%.
At the current price of 229.41, it has a dividend yield of 0.45%, and its target price is 232.62. This is with a profit margin of *TBA, and total debt/equity of 1.14. CR Bard Inc. (NYSE:BCR) has a P/E of 101.86, as well as a forward P/E of 20.47.
With a current EPS of 2.26, and a forecasted EPS growth for next year at 10.74%,CR Bard Inc. (NYSE:BCR) has had a EPS growth for the past five years at -19.80%. For the next five years EPS growth is projected to be 10.80%.
Performance for the year is 28.80%. Since its IPO date on 4/6/1983, the total performance to date is 21.85%.
Volume today for CR Bard Inc. (NYSE:BCR), is 234356, while its average volume is 477.21. Whilst the total gain today was -0.26%, it did have a day high of -4.08%.
Volatility for this week has been at 1.07%, and 1.24% for the month. The 52-week low for CR Bard Inc., BCR has been 33.70%, while the 52-week-high has reached -4.08%.
Looking at its return of investments, which is 6.40%, and its return on assets is *TBA. CR Bard Inc. (NYSE:BCR) has an operating margin of *TBA. With a sales growth of 6.60% quarter over quarter. Bearing in mind that CR Bard Inc., BCR is in the sector Healthcare, its long-term debt/equity is 0.78, and has a current ratio of 1.5 and 1.2 for quick ratio.
So what is the value of CR Bard Inc.? Well its PEG is 9.43, and the P/S is 4.89, along with a P/B of 11.66. Meanwhile it has a p/cash of 22.18.